Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

880 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer.
Akman M, Monteleone C, Doronzo G, Godel M, Napoli F, Merlini A, Campani V, Nele V, Balmas E, Chontorotzea T, Fontana S, Digiovanni S, Barbu FA, Astanina E, Jafari N, Salaroglio IC, Kopecka J, De Rosa G, Mohr T, Bertero A, Righi L, Novello S, Scagliotti GV, Bussolino F, Riganti C. Akman M, et al. Among authors: de rosa g. J Exp Clin Cancer Res. 2024 Aug 7;43(1):219. doi: 10.1186/s13046-024-03142-4. J Exp Clin Cancer Res. 2024. PMID: 39107857 Free PMC article.
Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance.
Fattore L, Cafaro G, Di Martile M, Campani V, Sacconi A, Liguoro D, Marra E, Bruschini S, Stoppoloni D, Cirombella R, De Nicola F, Pallocca M, Ruggiero CF, Castaldo V, Catizone A, Del Bufalo D, Viglietto G, Vecchione A, Blandino G, Aurisicchio L, Fanciulli M, Ascierto PA, De Rosa G, Mancini R, Ciliberto G. Fattore L, et al. Among authors: de rosa g, de nicola f. Oncogene. 2023 Jan;42(4):293-307. doi: 10.1038/s41388-022-02547-9. Epub 2022 Nov 23. Oncogene. 2023. PMID: 36418472 Free PMC article.
MiR-182-3p targets TRF2 and impairs tumor growth of triple-negative breast cancer.
Dinami R, Pompili L, Petti E, Porru M, D'Angelo C, Di Vito S, Rizzo A, Campani V, De Rosa G, Bruna A, Serra V, Mano M, Giacca M, Leonetti C, Ciliberto G, Tarsounas M, Stoppacciaro A, Schoeftner S, Biroccio A. Dinami R, et al. Among authors: de rosa g. EMBO Mol Med. 2023 Jan 11;15(1):e16033. doi: 10.15252/emmm.202216033. Epub 2022 Nov 25. EMBO Mol Med. 2023. PMID: 36426578 Free PMC article.
Correction: TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer.
Akman M, Monteleone C, Doronzo G, Godel M, Napoli F, Merlini A, Campani V, Nele V, Balmas E, Chontorotzea T, Fontana S, Digiovanni S, Alice Barbu F, Astanina E, Jafari N, Chiara Salaroglio I, Kopecka J, De Rosa G, Mohr T, Bertero A, Righi L, Novello S, Vittorio Scagliotti G, Bussolino F, Riganti C. Akman M, et al. Among authors: de rosa g. J Exp Clin Cancer Res. 2024 Aug 29;43(1):244. doi: 10.1186/s13046-024-03170-0. J Exp Clin Cancer Res. 2024. PMID: 39198838 Free PMC article. No abstract available.
CXCL12-loaded-hydrogel (CLG): A new device for metastatic circulating tumor cells (CTCs) capturing and characterization.
Portella L, Bertolini G, Guardascione G, Di Febbraro DG, Ieranò C, D'Alterio C, Rea G, Napolitano M, Santagata S, Trotta AM, Camerlingo R, Scarpa E, Cecere SC, Ottaiano A, Palumbo G, Morabito A, Somma T, De Rosa G, Mayol L, Pacelli R, Pignata S, Scala S. Portella L, et al. Among authors: de rosa g. Heliyon. 2024 Jul 31;10(15):e35524. doi: 10.1016/j.heliyon.2024.e35524. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39170328 Free PMC article.
CT-radiomics and pathological tumor response to systemic therapy: A predictive analysis for colorectal liver metastases. Development and internal validation of a clinical-radiomic model.
Ammirabile A, Cavinato L, Ferro CAP, Fiz F, Savino MS, Russolillo N, Balbo Mussetto A, Ragaini EM, Lanza E, Akpinar R, Procopio F, Francone M, Terracciano LM, Gallo T, De Rosa G, Ferrero A, Di Tommaso L, Ieva F, Torzilli G, Viganò L. Ammirabile A, et al. Among authors: de rosa g. Eur J Surg Oncol. 2024 Dec 16;51(3):109557. doi: 10.1016/j.ejso.2024.109557. Online ahead of print. Eur J Surg Oncol. 2024. PMID: 39729863
Self-assembling nanoparticles for delivery of miR-603 and miR-221 in glioblastoma as a new strategy to overcome resistance to temozolomide.
Abate M, Porru M, Campani V, Leonetti C, Nele V, Di Paola R, De Martino M, Russo M, Tathode M, Cossu AM, Bocchetti M, Angelillo A, Ianniello M, Petrillo N, Savarese G, Monica RD, Chiariotti L, Addeo R, Caraglia M, De Rosa G, Zappavigna S. Abate M, et al. Among authors: de rosa g. J Control Release. 2025 Jan 10;377:458-469. doi: 10.1016/j.jconrel.2024.11.039. Epub 2024 Nov 29. J Control Release. 2025. PMID: 39577464
Nanoparticles encapsulating phosphatidylinositol derivatives promote neuroprotection and functional improvement in preclinical models of ALS via a long-lasting activation of TRPML1 lysosomal channel.
Tedeschi V, Nele V, Valsecchi V, Anzilotti S, Vinciguerra A, Zucaro L, Sisalli MJ, Cassiano C, De Iesu N, Pignataro G, Canzoniero LMT, Pannaccione A, De Rosa G, Secondo A. Tedeschi V, et al. Among authors: de rosa g. Pharmacol Res. 2024 Dec;210:107491. doi: 10.1016/j.phrs.2024.107491. Epub 2024 Nov 2. Pharmacol Res. 2024. PMID: 39491634 Free article.
880 results